Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Enterprise ValueMarket Capitalization

Immuneering (IMRX) Gross Margin: 2020-2022

Historic Gross Margin for Immuneering (IMRX) over the last 3 years, with Dec 2022 value amounting to 100.00%.

  • Immuneering's Gross Margin rose 10877.00% to 100.00% in Q4 2022 from the same period last year, while for Dec 2022 it was 50.11%, marking a year-over-year increase of 555.00%. This contributed to the annual value of 50.11% for FY2022, which is 555.00% up from last year.
  • Latest data reveals that Immuneering reported Gross Margin of 100.00% as of Q4 2022, which was up 101.61% from 49.60% recorded in Q3 2022.
  • In the past 5 years, Immuneering's Gross Margin ranged from a high of 100.00% in Q4 2022 and a low of -8.77% during Q4 2021.
  • Its 3-year average for Gross Margin is 47.46%, with a median of 49.60% in 2022.
  • Per our database at Business Quant, Immuneering's Gross Margin plummeted by 3,762bps in 2021 and then soared by 10,877bps in 2022.
  • Over the past 3 years, Immuneering's Gross Margin (Quarterly) stood at 28.85% in 2020, then slumped by 3,762bps to -8.77% in 2021, then spiked by 10,877bps to 100.00% in 2022.
  • Its Gross Margin stands at 100.00% for Q4 2022, versus 49.60% for Q3 2022 and 49.23% for Q2 2022.